Healthcare Market Research Reports & Industry Analysis

Publications found: 73,128

Sort by:

Global Enteral Feeding Formulas Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... manufacturers of Enteral Feeding Formulas, with price, sales, revenue and global market share of Enteral Feeding Formulas in 2017 and 2018. Chapter 3, the Enteral Feeding Formulas competitive situation, sales, revenue and global market share ...

May 2019 122 pages

Global Animal Pharm Antibiotics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... manufacturers of Animal Pharm Antibiotics, with price, sales, revenue and global market share of Animal Pharm Antibiotics in 2017 and 2018. Chapter 3, the Animal Pharm Antibiotics competitive situation, sales, revenue and global market share ...

May 2019 136 pages

Global Anticoagulants Market: Size, Trends & Forecasts (2019-2023 Edition)

US$ 800.00

... report entitled “Global Anticoagulants Market (2019-2023 Edition)” provides an in-depth analysis of the global anticoagulants market with description of market size and growth. The analysis include market share by segment ...

April 2019 69 pages

Global Antifungal Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Antifungal Drugs in global market, especially in North America, Europe ...

April 2019 116 pages

Global Acne (Medication and Therapeutic Devices) Treatment Market: Size, Trends & Forecasts (2019-2023 Edition)

US$ 850.00

... entitled “Global Acne (Medication and Therapeutic Devices) Treatment Market: Size, Trends & Forecasts (2019-2023 Edition)”, provides an analysis of the global Acne treatment market ... widely used by large number of population for acne treatment. The global acne treatment market has shown upward trends over the ...

April 2019 75 pages

Global Coronary Stents Market: Size, Trends & Forecasts (2019-2023)

US$ 850.00

... REPORT The report titled “Global Coronary Stents Market: Size, Trends & Forecasts (2019-2023)” provides analysis of the coronary stents market with detailed analysis of the market size by value and segments ...

April 2019 73 pages

Healthcare Artificial Intelligence (AI) - Global Market Outlook (2017-2026)

US$ 4,150.00

According to Stratistics MRC, the Global Healthcare Artificial Intelligence (AI) Market is accounted for $0.95 billion in 2017 and is expected to reach ... this region. Some of the key players profiled in the Healthcare Artificial Intelligence (AI) Market include Zebra Medical Vision Ltd, Sophia Genetics, Enlitic ...

April 2019 154 pages

Translational Regenerative Medicines - Global Market Outlook (2017-2026)

US$ 4,150.00

According to Stratistics MRC, the Global Translational Regenerative Medicines Market is growing at a CAGR of 13.9% from 2017 to 2026. Factors such ... in the U.S. Some of the key players profiled in the Translational Regenerative Medicines Market include Vericel Corporation, Gamida Cell Ltd., Athersys, Inc ...

April 2019 158 pages

Artificial Intelligence in Healthcare Market: World Market Analysis By Component (Hardware, Software, Services), Technology (Natural Language Processing, Machine Learning), End User, By Region, By Country (2019 Edition): Forecast to 2024 -- By End User (Healthcare Providers, Pharmaceutical Organizations, Others), By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, UK, Germany, China, India)

US$ 2,400.00

... , the report aims to present the analysis of Global Artificial Intelligence in Healthcare Market. The report analyzes the artificial intelligence in healthcare market, By Component (Hardware, Software and Services), By Technology (Natural ...

April 2019 215 pages

Sepsis - Pipeline Review, H1 2019

US$ 2,000.00

... releases. The Sepsis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Sepsis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2019 320 pages

Nicotine Addiction - Pipeline Review, H1 2019

US$ 2,000.00

... . The Nicotine Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Nicotine Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

April 2019 65 pages

BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H1 2019

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) development ...

April 2019 127 pages

G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) - Pipeline Review, H1 2019

US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding G Protein Coupled Bile Acid Receptor 1 (G Protein Coupled Receptor GPCR19 or Membrane Type Receptor For Bile Acids or hBG37 or GPR131 or GPBAR1) development landscape Develop ...

April 2019 28 pages

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Pipeline Review, H1 2019

US$ 3,500.00

... Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

April 2019 50 pages

Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Pipeline Review, H1 2019

US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) development ...

April 2019 104 pages

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H1 2019

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) development ...

April 2019 40 pages

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019

US$ 3,500.00

... Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

April 2019 123 pages

Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H1 2019

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) development landscape Develop and design ...

April 2019 47 pages

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2019

US$ 3,500.00

... Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

April 2019 58 pages

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2019

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) development landscape Develop and design ...

April 2019 61 pages

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2019

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) development landscape Develop and ...

April 2019 73 pages

Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H1 2019

US$ 3,500.00

... by Companies/Universities. It also reviews key players involved in Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) targeted therapeutics development with respective active and ...

April 2019 36 pages

Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H1 2019

US$ 3,500.00

... . It also reviews key players involved in Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) targeted therapeutics development with respective ...

April 2019 37 pages

C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H1 2019

US$ 3,500.00

... C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

April 2019 68 pages

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2019

US$ 3,500.00

... C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

April 2019 85 pages

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H1 2019

US$ 3,500.00

... Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

April 2019 203 pages

Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H1 2019

US$ 3,500.00

... Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

April 2019 64 pages

Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H1 2019

US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) development landscape Develop ...

April 2019 71 pages

Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Pipeline Review, H1 2019

US$ 3,500.00

... Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

April 2019 81 pages

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H1 2019

US$ 3,500.00

... T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

April 2019 77 pages

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) development ...

April 2019 85 pages

Global Animal Blood Plasma and Derivatives Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... manufacturers of Animal Blood Plasma and Derivatives, with price, sales, revenue and global market share of Animal Blood Plasma and Derivatives in 2017 and 2018. Chapter 3, the Animal Blood Plasma and ...

April 2019 119 pages

Global Nasal Drug Delivery Technology Market 2019 by Company, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

SCOPE OF THE REPORT: The global Nasal Drug Delivery Technology market is valued at million USD in 2018 and is expected to reach million ... in 2024, with a CAGR of xx%. This report studies the Nasal Drug Delivery Technology market status and outlook of Global and major regions, from angles of players, countries ...

April 2019 115 pages

Global Non-Invasive Prenatal Testing (NIPT) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... the top manufacturers of Non-Invasive Prenatal Testing (NIPT), with price, sales, revenue and global market share of Non-Invasive Prenatal Testing (NIPT) in 2017 and 2018. Chapter 3, the Non-Invasive Prenatal Testing (NIPT) competitive situation, sales ...

April 2019 137 pages

Global Thyroid Gland Disorders Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... the top manufacturers of Thyroid Gland Disorders Treatment, with price, sales, revenue and global market share of Thyroid Gland Disorders Treatment in 2017 and 2018. Chapter 3, the Thyroid Gland Disorders Treatment competitive situation, sales ...

April 2019 118 pages

Global Urinary Tract Infection Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... the top manufacturers of Urinary Tract Infection Therapeutics, with price, sales, revenue and global market share of Urinary Tract Infection Therapeutics in 2017 and 2018. Chapter 3, the Urinary Tract Infection Therapeutics competitive situation, sales ...

April 2019 123 pages

Global Vascular Bypass Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

US$ 3,480.00

... million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Vascular Bypass in global market, especially in North America, Europe ...

April 2019 118 pages

2019 Abdominal Abscess Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Abdominal Abscess Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Abdominal Abscess. It presents in-depth analysis of Abdominal Abscess clinical trials across markets and companies ...

April 2019 43 pages

2019 Abdominal Aortic Aneurysm Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Abdominal Aortic Aneurysm Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Abdominal Aortic Aneurysm. It presents in-depth analysis of Abdominal Aortic Aneurysm clinical trials ...

April 2019 71 pages

2019 Abdominal Obesity Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Abdominal Obesity Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Abdominal Obesity. It presents in-depth analysis of Abdominal Obesity clinical trials across markets and companies ...

April 2019 69 pages

2019 Abdominal Pain Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Abdominal Pain Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Abdominal Pain. It presents in-depth analysis of Abdominal Pain clinical trials across markets and companies ...

April 2019 221 pages

2019 Abortion Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Abortion Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Abortion. It presents in-depth analysis of Abortion clinical trials across markets and companies ...

April 2019 301 pages

2019 Abscess Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Abscess Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Abscess. It presents in-depth analysis of Abscess clinical trials across markets and companies ...

April 2019 116 pages

2019 Acid Indigestion (Heartburn) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Acid Indigestion (Heartburn) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Acid Indigestion (Heartburn). It presents in-depth analysis of Acid Indigestion (Heartburn) clinical trials ...

April 2019 45 pages

2019 Acromegaly Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Acromegaly Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Acromegaly. It presents in-depth analysis of Acromegaly clinical trials across markets and companies ...

April 2019 96 pages

2019 Actinic Keratosis (Solar Keratosis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Actinic Keratosis (Solar Keratosis) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Actinic Keratosis (Solar Keratosis). It presents in-depth analysis of Actinic Keratosis (Solar Keratosis) clinical trials ...

April 2019 248 pages

2019 Acute and Sub Acute Bursitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

... report- “2019 Acute and Sub Acute Bursitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Acute and Sub Acute Bursitis. It presents ...

April 2019 72 pages

2019 Acute Asthma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Acute Asthma Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Acute Asthma. It presents in-depth analysis of Acute Asthma clinical trials across markets and companies ...

April 2019 75 pages

2019 Acute Bronchitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Acute Bronchitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Acute Bronchitis. It presents in-depth analysis of Acute Bronchitis clinical trials across markets and companies ...

April 2019 244 pages

2019 Acute Heart Failure Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 1,619.00

The global clinical trial report- “2019 Acute Heart Failure Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Acute Heart Failure. It presents in-depth analysis of Acute Heart Failure clinical trials ...

April 2019 184 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...